EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Effects of corticosteroid pretreatment in patients with spinal dural arteriovenous fistula

Matteo Palermo, Gianluca Trevisi, Alessandro Olivi, Francesco Doglietto, Alessio Albanese, Carmelo Lucio Sturiale iD

European Spine Journal · 23.07.2026

DOI: 10.1007/s00586-026-10224-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Spine Journal, online erschienen am 23.07.2026. Verfasst von Matteo Palermo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Spinal arteriovenous fistulas, especially dural types (SdAVFs), are often misdiagnosed as inflammatory myelopathies, leading to inadvertent corticosteroid therapy. This study systematically evaluated the clinical consequences of steroid pretreatment in SdAVF and its underlying pathophysiological mechanisms.

Methods

A PRISMA-compliant systematic review and pooled analysis were conducted across PubMed, Scopus, and Embase on October 10th, 2025. Quantitative data on patients receiving corticosteroids before SdAVF diagnosis were extracted, including demographic, clinical, radiologic, and outcome measures. Comparative and paired analyses (χ², Kruskal-Wallis and Wilcoxon tests) assessed associations between steroid exposure, fistula location, and modified Aminoff–Logue Scale (mALS) outcomes.

Results

Seventy-one studies, including 161 patients from case series and 86 from pooled case reports, were included. Across the pooled cohort of case reports, 81.4% of steroid-treated patients experienced neurological worsening. In case series, worsening remained frequent, occurring in 54.7% of patients. Paired analysis confirmed significant deterioration in gait, urinary, and fecal mALS domains after steroid administration ( p < 0.01, p < 0.001, p = 0.006).

Conclusions

Steroid therapy in SdAVF has been associated with neurological deterioration, due to possibly aggravating venous hypertension and precipitating irreversible myelopathy. Clinicians should avoid empiric corticosteroids in unexplained progressive myelopathy and pursue early vascular imaging to exclude SdAVF.

Schlagwörter

Stichwörter der Autor:innen

Arteriovenous fistulaDuralEdemaSpineSteroid

Autor:innen und Institutionen

  • Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Department of Neurosciences, Imaging and Clinical Sciences, G. D'Annunzio University, Chieti-Pescara, Italy.
  • Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. cropcircle.2000@virgilio.it.

ORCID-Profile: Carmelo Lucio Sturiale

Förderung

  • Università Cattolica del Sacro Cuore

Zitieren

APA

Palermo, M., Trevisi, G., Olivi, A., Doglietto, F., Albanese, A., & Sturiale, C. L. (2026). Effects of corticosteroid pretreatment in patients with spinal dural arteriovenous fistula. European Spine Journal. https://doi.org/10.1007/s00586-026-10224-8

Vancouver

Palermo M, Trevisi G, Olivi A, Doglietto F, Albanese A, Sturiale CL. Effects of corticosteroid pretreatment in patients with spinal dural arteriovenous fistula. European Spine Journal. 2026. doi:10.1007/s00586-026-10224-8

BibTeX
@article{Palermo2026,
  author = {Palermo, Matteo and Trevisi, Gianluca and Olivi, Alessandro and Doglietto, Francesco and Albanese, Alessio and Sturiale, Carmelo Lucio},
  title = {Effects of corticosteroid pretreatment in patients with spinal dural arteriovenous fistula},
  journal = {European Spine Journal},
  year = {2026},
  doi = {10.1007/s00586-026-10224-8}
}
Kostenlos starten →